Evidence map›Paper›PMID 40034572›Full record

ArticleEClinicalMedicine2025

Use of food restrictions to prevent infections in paediatric patients with cancer and haematopoietic cell transplantation recipients: a systematic review and clinical practice guideline.

Robert Phillips, Brian T Fisher, Elena J Ladas, Priya Patel, Paula D Robinson, L Lee Dupuis, Roland A Ammann, Melissa P Beauchemin, Fabianne Carlesse, Elio Castagnola and 13 more

Abstract read
In one paragraph

Article in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. The Role of Gut Microbiota in Acute Myeloid Leukemia.Journal of clinical medicine · 2026
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Robert PhillipsCentre for Reviews and Dissemination, University of York, York YO10 5DD, UK.
Brian T FisherDivision of Infectious Diseases, Children's Hospital of Philadelphia, 3400 Civic Center Blvd, Philadelphia, PA 19104, USA.
Elena J LadasDivision of Pediatric Hematology/Oncology/Stem Cell Transplant, Columbia University Irving Medical Center, 3959 Broadway, New York, NY 10032, USA.
Priya PatelPediatric Oncology Group of Ontario, 480 University Ave, Suite 1014, Toronto, ON M5G 1V2, Canada.
Paula D RobinsonPediatric Oncology Group of Ontario, 480 University Ave, Suite 1014, Toronto, ON M5G 1V2, Canada.
L Lee DupuisDepartment of Pharmacy, The Hospital for Sick Children, 555 University Ave, Toronto, ON M5G 1X8, Canada.
Roland A AmmannStatConsult Ammann, Pleerweg 92, Burgdorf 3400, Switzerland.
Melissa P BeaucheminColumbia University Irving Medical Center/Herbert Irving Comprehensive Cancer Center, Columbia University School of Nursing, 560 West 168th Street, New York, NY 10032, USA.
Fabianne CarlessePediatric Oncology Institute, GRAACC/Federal University of Sao Paulo, Rua Pedro de Toledo, 572 - Vila Clementino, São Paulo, SP 04039-001, Brazil.
Elio CastagnolaInfectious Diseases Unit, Department of Pediatrics, IRCCS Istituto Giannina Gaslini, Genova 16147, Italy.
Bonnie L DavisNot applicable (patient representative).
Kirsten EfremovNot applicable (patient representative).
Caitlin W ElgartenDivision of Oncology, Children's Hospital of Philadelphia, 3400 Civic Center Blvd, Philadelphia, PA 19104, USA.
Andreas H GrollInfectious Disease Research Program, Center for Bone Marrow Transplantation, Department of Pediatric Hematology/Oncology, University Children's Hospital, Muenster, Albert-Schweitzer-Campus 1, Münster 48149, Germany.
Gabrielle M HaeuslerDepartment of Infectious Diseases Unit, Royal Children's Hospital Melbourne, 50 Flemington Road Parkville, Victoria 3052, Australia.
Christa KoenigDivision of Pediatric Hematology/Oncology, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland.
Alisa MorrisDietetics Department, Great Ormond Street Hospital, Great Ormond Street, London WC1N 3JH, UK.
Maria Elena SantolayaDepartment of Pediatrics, Hospital Dr. Luis Calvo Mackenna, Faculty of Medicine, Universidad de Chile, Av. Antonio Varas 360 Providencia, Santiago, Chile.
Daniela SpinelliNot applicable (patient representative).
Wim J E TissingPrincess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, Netherlands.
Joshua WolfDivision of Infectious Disease, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105-3678, USA.
Lillian SungChild Health Evaluative Sciences, The Hospital for Sick Children, 555 University Ave, Toronto, ON M5G 1X8, Canada.
Thomas LehrnbecherDepartment of Pediatrics, Division of Hematology, Oncology and Hemostaseology, Goethe University, Frankfurt, Theodor-Stern-Kai 7, Frankfurt/Main 60590, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Food restrictions during periods of neutropenia have been widely used in oncology settings to prevent infections. As there is a lack of clearly demonstrated effectiveness, this strategy is being increasingly questioned. Methods: A multi-national panel of 23 individuals was convened to develop a clinical practice guideline (CPG) on the use of food restrictions to prevent infections in paediatric patients with cancer and haematopoietic cell transplantation (HCT) recipients. It included representation from persons with lived experience and physicians, dieticians, nurses, pharmacists and guideline methodologists working in paediatric oncology/HCT or infectious diseases. Panel members (female n = 15; 65%) were from North America (12, 52%), Europe (8, 35%), South America (2, 9%) and Australia (1, 4%). The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to formulate the CPG recommendations based on a systematic review of randomised controlled trials (RCTs). MEDLINE, MEDLINE in-Process and Embase databases were searched from January 1, 1980, to May 7, 2024, with a broad strategy which combined subject headings and text words relating to neutropenia, infection and diet. Findings: The systematic review, which provided the evidence base for the CPG recommendations, identified 4312 unique citations, of which 52 were retrieved for full-text evaluation. Eight RCTs met the eligibility criteria and informed panel deliberations. Although there was clinical heterogeneity in the food restrictions evaluated, data were consistent in suggesting that food restrictions lack clinically significant benefit in preventing infections. The panel made two conditional recommendations against the use of food restrictions in a) paediatric patients with cancer receiving chemotherapy and b) in the setting of allogeneic and autologous HCT. The panel developed a good practice statement to emphasise the importance of health care organisations and families adhering to local food safety practices. Interpretation: This CPG provides the first evidence-based recommendations on use of food restrictions to prevent infections in children and adolescents undergoing chemotherapy and paediatric haematopoietic cell transplant recipients. Funding: This CPG was funded and developed through the POGO Guidelines Program.

Indexed as

Food restrictionsNeutropenic dietPaediatric oncologyPractice guideline

Identifiers

PMID40034572
PMCPMC11872571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.